论文部分内容阅读
目的观察静脉注射胺碘酮和维拉帕米治疗阵发性室上性心动过速(PSVT)的疗效。方法静脉注射胺碘酮治疗33例PSVT,与维拉帕米静脉注射治疗39例PSVT对比观察。结果胺碘酮组和维拉帕米组有效率分别为63.6%和84.6%,差异有统计学意义(P<0.05);复律时间:胺碘酮组(21±12.4)min明显慢于维拉帕米组的(13.6±9.7)min(P<0.05)。结论胺碘酮治疗PSVT疗效确切安全,可作为急诊治疗PSVT的一线药物。
Objective To observe the efficacy of intravenous amiodarone and verapamil in the treatment of paroxysmal supraventricular tachycardia (PSVT). Methods Thirty-three cases of PSVT were treated with amiodarone intravenously, and 39 cases of PSVT were treated with verapamil intravenously. Results The effective rates of amiodarone group and verapamil group were 63.6% and 84.6%, respectively, with significant difference (P <0.05). The time of cardioversion was significantly lower in amiodarone group (21 ± 12.4) min than in dimension Laparib group (13.6 ± 9.7) min (P <0.05). Conclusions Amiodarone is safe and effective in the treatment of PSVT and can be used as the first-line drug for emergency treatment of PSVT.